CME Group Inc [CME] stock prices are up 0.78% to $242.53 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CME shares have gain 3.47% over the last week, with a monthly amount glided 4.22%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CME Group Inc [NASDAQ: CME] stock has seen the most recent analyst activity on January 06, 2025, when Citigroup downgraded its rating to a Neutral and also revised its price target to $250 from $255. Previously, Redburn Atlantic downgraded its rating to Neutral on October 08, 2024, and kept the price target unchanged to $244. On September 27, 2024, RBC Capital Mkts initiated with a Sector Perform rating and assigned a price target of $235 on the stock. TD Cowen started tracking the stock assigning a Hold rating and suggested a price target of $221 on September 26, 2024. BofA Securities downgraded its rating to a Underperform and reduced its price target to $177 on September 03, 2024. JP Morgan downgraded its rating to Underweight for this stock on June 21, 2024, and downed its price target to $187. In a note dated January 08, 2024, Barclays downgraded an Equal Weight rating on this stock and revised its target price from $244 to $222.
The stock price of CME Group Inc [CME] has been fluctuating between $186.08 and $242.98 over the past year. Currently, Wall Street analysts expect the stock to reach $230.2 within the next 12 months. CME Group Inc [NASDAQ: CME] shares were valued at $242.53 at the most recent close of the market. An investor can expect a potential drop of -5.08% based on the average CME price forecast.
Analyzing the CME fundamentals
The CME Group Inc [NASDAQ:CME] reported sales of 6.04B for trailing twelve months, representing a surge of 18.43%. Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at 0.64%, Pretax Profit Margin comes in at 0.74%, and Net Profit Margin reading is 0.57%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.13 and Total Capital is 0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 239.48 points at the first support level, and at 236.43 for the second support level. However, for the 1st resistance point, the stock is sitting at 244.22, and for the 2nd resistance point, it is at 245.91.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 14.46, the price to book ratio is 3.09 and price to earnings (TTM) ratio is 25.50.
Transactions by insiders
Recent insider trading involved SHEPARD WILLIAM R, Director, that happened on Jan 16 ’25 when 1369.0 shares were purchased. Director, SHEPARD WILLIAM R completed a deal on Jan 16 ’25 to buy 60.0 shares. Meanwhile, Director SHEPARD WILLIAM R bought 264.0 shares on Dec 27 ’24.
